Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/15/1996 | WO1996024258A1 A LOW PHOSPHORUS ANIMAL FEED CONTAINING 1α-HYDROXYLATED VITAMIN D COMPOUNDS |
08/15/1996 | WO1996011685A3 Use of indole derivatives for the treatment of various diseases |
08/15/1996 | WO1996007397A3 Delivery of solid drug compositions |
08/15/1996 | CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
08/15/1996 | CA2210685A1 Human pancreatic cell lines: developments and uses |
08/15/1996 | CA2210664A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
08/14/1996 | EP0726321A2 Method for production of arachidonic acid |
08/14/1996 | EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration |
08/14/1996 | EP0726074A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
08/14/1996 | EP0725796A1 Growth differentiation factor-10 |
08/14/1996 | EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists |
08/14/1996 | EP0725648A1 Hepatoselective pharmaceutical actives |
08/14/1996 | EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
08/14/1996 | EP0725573A1 Ready-to-eat cereals containing extruded pre-wetted psyllium |
08/14/1996 | EP0725571A1 Psyllium-enriched dough products and method for making the same |
08/14/1996 | EP0618920B1 Novel phosphono-succinic acid derivatives, process for producing them and medicaments containing these compounds |
08/14/1996 | DE19603797A1 Neue Formen von Paroxetin-Hydrochlorid New forms of paroxetine hydrochloride |
08/14/1996 | CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof |
08/14/1996 | CN1128657A Composition for anti hypertriglyceridemia |
08/13/1996 | US5545659 Hydroxylamines with hypoglycemic activity |
08/13/1996 | US5545635 Inhibiting bone loss with equilenin |
08/13/1996 | US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation |
08/13/1996 | US5545628 Pharmaceutical composition containing fenofibrate |
08/13/1996 | US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell |
08/13/1996 | US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody |
08/13/1996 | US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody |
08/11/1996 | CA2169136A1 Use of src sh2 specific compounds to treat a bone resorption disease |
08/08/1996 | WO1996023896A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
08/08/1996 | WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors |
08/08/1996 | WO1996023517A1 Anti-obesity proteins |
08/08/1996 | WO1996023516A1 Anti-obesity proteins |
08/08/1996 | WO1996023515A1 Anti-obesity proteins |
08/08/1996 | WO1996023514A1 Anti-obesity proteins |
08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
08/08/1996 | WO1996023501A1 Methods of decreasing serum calcium levels |
08/08/1996 | CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors |
08/08/1996 | CA2211664A1 Anti-obesity proteins |
08/08/1996 | CA2211662A1 Anti-obesity proteins |
08/08/1996 | CA2211656A1 Anti-obesity proteins |
08/08/1996 | CA2211530A1 Methods of decreasing serum calcium levels |
08/07/1996 | EP0725079A1 Anti-obesity proteins |
08/07/1996 | EP0725078A1 Anti-obesity proteins |
08/07/1996 | EP0724877A1 Mixture of fenofibrate and vitamin E and its therapeutic use |
08/07/1996 | EP0724583A1 Pyridazino quinoline compounds |
08/07/1996 | EP0724579A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
08/07/1996 | EP0724578A1 Amine derivatives as calcium channel antagonists |
08/07/1996 | EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
08/07/1996 | EP0724561A1 Calcium receptor-active arylalkyl amines |
08/07/1996 | EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
08/07/1996 | EP0724427A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
08/07/1996 | EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists |
08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
08/07/1996 | CN1032470C Method for processing sulfur-containing heterocyclic compound |
08/06/1996 | US5543561 Acyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds |
08/06/1996 | US5543542 Reacting phosphonosulfonate with oxidizing agent, reacting product with hydroxylamine protecting agent, then with silyl bromide or iodide |
08/06/1996 | US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue |
08/01/1996 | WO1996023067A1 Human interleukin-1 receptor accessory protein |
08/01/1996 | WO1996022976A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
08/01/1996 | WO1996022966A1 Cell adhesion inhibitors |
08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
08/01/1996 | WO1996022782A1 Novel highly potent agonists of growth hormone releasing hormone |
08/01/1996 | WO1996022776A1 Dermatological use of vitamin d derivatives |
08/01/1996 | CA2211181A1 Cell adhesion inhibitors |
08/01/1996 | CA2211122A1 Novel highly potent agonists of growth hormone releasing hormone |
08/01/1996 | CA2210884A1 Dermatological use of vitamin d derivatives |
08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
07/31/1996 | EP0723956A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them |
07/31/1996 | EP0723780A2 2-Phenyl-3-azoylbenzothiopenes for decreasing serum calcium levels |
07/31/1996 | EP0723537A1 Benzothiophenes and related compounds as estrogen agonists |
07/31/1996 | EP0723438A1 Substituted urea and isothiourea derivatives as no synthase inhibitors |
07/31/1996 | EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
07/31/1996 | CN1127657A Tonic hypoglycemic capsule and preparing process thereof |
07/31/1996 | CN1127637A Agent for reducing blood suger containing powder of silkworm as effective ingredient and making of same |
07/31/1996 | CA2168315A1 Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
07/30/1996 | US5541229 Benzimidazoles and medicaments containing these compounds |
07/30/1996 | US5541204 Aryloxypropanolamine β 3 adrenergic agonists |
07/30/1996 | US5541159 Calcitonin derivatives |
07/30/1996 | US5540917 Biomass lipase inhibitor useful for treating adiposity |
07/30/1996 | CA1338495C Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them |
07/30/1996 | CA1338493C Bicyclic aromatic derivatives; process for preparing the same and their use in cosmetics |
07/25/1996 | WO1996022306A1 Novel peptide |
07/25/1996 | WO1996022290A1 Compounds having effects on serotonin-related systems |
07/25/1996 | WO1996022279A1 New derivatives of glycylanilides, preparation and therapeutical application |
07/25/1996 | WO1996022095A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
07/25/1996 | WO1996022092A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
07/25/1996 | CA2211342A1 New derivatives of glycylanilides, preparation and therapeutical application |
07/25/1996 | CA2210220A1 Compounds having effects on serotonin-related systems |
07/25/1996 | CA2208837A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
07/24/1996 | EP0722941A2 Compounds having effects on serotonin-related systems |
07/24/1996 | EP0722431A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
07/24/1996 | EP0722319A1 Anthracyclinone derivatives and their use in amyloidosis |
07/24/1996 | EP0722276A1 Psyllium enriched pasta products and method for making same |
07/24/1996 | EP0630184B1 Effect of particle-size distribution of cellulose ethers on palatability of compositions |
07/24/1996 | CN1127528A Modified alpha-lactalbumin |
07/24/1996 | CN1127508A Fused benzazepine derivative and pharmaceutical composition containing the same |
07/23/1996 | US5538978 9-purinyl phosphonic acid derivatives |
07/23/1996 | US5538957 Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds |
07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |